View Older Stories View More Recent Stories

Feb 18, 2020 08:22AM Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
Feb 11, 2020 08:35AM Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers
Jan 27, 2020 08:25AM Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit
Jan 9, 2020 09:00AM Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties
Dec 5, 2019 09:00AM Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research
Oct 16, 2019 09:30AM Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies
Oct 7, 2019 09:45AM Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of Directors
Sep 12, 2019 08:00AM Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA
Jun 25, 2019 09:00AM Cannabics Pharmaceuticals Appoints Two Independent Directors
Jun 25, 2019 09:00AM /C O R R E C T I O N -- Cannabics Pharmaceuticals Inc./
Jun 4, 2019 09:00AM Cannabics Pharmaceuticals to Participate at the LIFT & Co. Conference in Toronto, Canada
May 30, 2019 09:00AM Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California
Apr 25, 2019 09:00AM Cannabics Pharmaceuticals' CEO to Present at the Planet MicroCap Conference in Las Vegas and at the ThinkEquity Conference in New York City
Apr 17, 2019 09:00AM Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies
Mar 12, 2019 10:56AM SodaStream CEO Daniel Birnbaum to Join Seedo Board
Mar 6, 2019 09:00AM Cannabics Pharmaceuticals Closes Agreement With Wize Pharma
Mar 6, 2019 09:00AM Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics
Feb 19, 2019 08:30AM Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids
Feb 7, 2019 08:30AM Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics
Feb 7, 2019 08:30AM Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions
Jan 31, 2019 11:24AM Cannabics Pharmaceuticals Files Four New Provisional Patent Applications for Cannabinoid-Based Drugs and Treatments for Non-Epileptic Seizures and Tremors
Jan 24, 2019 08:30AM Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics' SR Capsules in Colombia
Jan 22, 2019 09:00AM Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos
Dec 31, 2018 11:13AM Cannabics Pharmaceuticals to be present during the J.P. Morgan Healthcare Conference In San Francisco
Dec 26, 2018 11:23AM Cannabics Pharmaceuticals Announces New Provisional Patent Application for Personalized Cannabimetic Compositions Modeling and Production
Dec 11, 2018 11:27AM Cannabics Pharmaceuticals Prepares ISO Application for Its Diagnostics Platform Towards Commercialization
Nov 28, 2018 09:48AM Cannabics Pharmaceuticals Announces New Provisional Patent Application for Magnetic Targeting of Cannabinoids
Nov 28, 2018 09:48AM /C O R R E C T I O N -- Cannabics Pharmaceuticals Inc./
View More Recent Stories View Older Stories